失眠症
医学
生活质量(医疗保健)
间接成本
成本效益
精神科
卫生经济学
医疗保健
公共卫生
风险分析(工程)
业务
护理部
经济增长
会计
经济
作者
Emerson M. Wickwire,Fadia T. Shaya,Steven M. Scharf
标识
DOI:10.1016/j.smrv.2015.11.004
摘要
Chronic insomnia is the most common sleep disorder among adults and is associated with a wide range of negative outcomes. This article reviews the economic consequences of the disorder and the cost effectiveness of insomnia treatments. First, the total costs of insomnia are reviewed; in aggregate these costs exceed $100 billion USD per year, with the majority being spent on indirect costs such as poorer workplace performance, increased health care utilization, and increased accident risk. Next, the deleterious impact of insomnia on quality of life and the impact of treatment on quality of life are briefly considered. Finally, ten published studies evaluating the cost effectiveness of both pharmacological and behavioral treatments for insomnia are reviewed in detail. A significant majority of studies reviewed found that the cost of treating primary and comorbid insomnia is less than the cost of not treating it. Treatments were generally found to be cost-effective using commonly employed standards, with treatment costs being recouped within 6–12 mo.
科研通智能强力驱动
Strongly Powered by AbleSci AI